<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Analg</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Analg</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Anesthesia and analgesia</journal-title></journal-title-group><issn pub-type="ppub">0003-2999</issn><issn pub-type="epub">1526-7598</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10823563</article-id><article-id pub-id-type="pmcid-ver">PMC10823563.1</article-id><article-id pub-id-type="pmcaid">10823563</article-id><article-id pub-id-type="pmcaiid">10823563</article-id><article-id pub-id-type="manuscript-id">NIHMS1957002</article-id><article-id pub-id-type="pmid">35343932</article-id><article-id pub-id-type="doi">10.1213/ANE.0000000000005976</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1957002</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1957002</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose: A Quality Improvement Project</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Nelson</surname><given-names initials="SD">Scott D.</given-names></name><degrees>PharmD, MS, CPHIMS, FAMIA</degrees><xref rid="A1" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McCoy</surname><given-names initials="AB">Allison B.</given-names></name><degrees>PhD, FAMIA</degrees><xref rid="A1" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rector</surname><given-names initials="H">Hayley</given-names></name><degrees>PharmD, BCPS</degrees><xref rid="A2" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Teare</surname><given-names initials="AJ">Andrew J.</given-names></name><degrees>PharmD, CAHIMS</degrees><xref rid="A3" ref-type="aff">&#8225;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barrett</surname><given-names initials="TW">Tyler W.</given-names></name><degrees>MD, MSCI, FACEP, FHRS</degrees><xref rid="A4" ref-type="aff">&#167;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sigworth</surname><given-names initials="EA">Elizabeth A.</given-names></name><degrees>BA</degrees><xref rid="A5" ref-type="aff">&#9553;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Q">Qingxia</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">&#9553;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names initials="DA">David A.</given-names></name><degrees>MD, PhD</degrees><xref rid="A6" ref-type="aff">&#182;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marcovitz</surname><given-names initials="DE">David E.</given-names></name><degrees>MD</degrees><xref rid="A7" ref-type="aff">#</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wright</surname><given-names initials="A">Adam</given-names></name><degrees>PhD, FACMI, FAMIA, FIAHSI</degrees><xref rid="A1" ref-type="aff">*</xref></contrib></contrib-group><aff id="A1"><label>*</label>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="A2"><label>&#8224;</label>Department of Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="A3"><label>&#8225;</label>Department of HealthIT, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="A4"><label>&#167;</label>Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="A5"><label>&#9553;</label>Department of Biostatistics, Vanderbilt University, Nashville, Tennessee</aff><aff id="A6"><label>&#182;</label>Department of Anesthesiology, Division of Pain Medicine, Anesthesiology, and Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="A7"><label>#</label>Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.</aff><author-notes><corresp id="CR1">Address correspondence to Scott D. Nelson, PharmD, MS, CPHIMS, FAMIA, Department of Biomedical Informatics, Vanderbilt University Medical Center, 2525 West End Ave #1475, Nashville, TN 37203. <email>scott.nelson@vanderbilt.edu</email>.</corresp><fn fn-type="COI-statement" id="FN1"><p id="P32">The authors declare no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>16</day><month>6</month><year>2022</year></pub-date><volume>135</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">454448</issue-id><fpage>26</fpage><lpage>34</lpage><pub-history><event event-type="nihms-submitted"><date><day>14</day><month>01</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>29</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>29</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-22 09:25:35.513"><day>22</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1957002.pdf"/><abstract id="ABS1"><sec id="S1"><title>BACKGROUND:</title><p id="P1">Patients taking high doses of opioids, or taking opioids in combination with other central nervous system depressants, are at increased risk of opioid overdose. Coprescribing the opioid-reversal agent naloxone is an essential safety measure, recommended by the surgeon general, but the rate of naloxone coprescribing is low. Therefore, we set out to determine whether a targeted clinical decision support alert could increase the rate of naloxone coprescribing.</p></sec><sec id="S2"><title>METHODS:</title><p id="P2">We conducted a before-after study from January 2019 to April 2021 at a large academic health system in the Southeast. We developed a targeted point of care decision support notification in the electronic health record to suggest ordering naloxone for patients who have a high risk of opioid overdose based on a high morphine equivalent daily dose (MEDD) &#8805;90 mg, concomitant benzodiazepine prescription, or a history of opioid use disorder or opioid overdose. We measured the rate of outpatient naloxone prescribing as our primary measure. A multivariable logistic regression model with robust variance to adjust for prescriptions within the same prescriber was implemented to estimate the association between alerts and naloxone coprescribing.</p></sec><sec id="S3"><title>RESULTS:</title><p id="P3">The baseline naloxone coprescribing rate in 2019 was 0.28 (95% confidence interval [CI], 0.24&#8211;0.31) naloxone prescriptions per 100 opioid prescriptions. After alert implementation, the naloxone coprescribing rate increased to 4.51 (95% CI, 4.33&#8211;4.68) naloxone prescriptions per 100 opioid prescriptions (<italic toggle="yes">P</italic> &lt; .001). The adjusted odds of naloxone coprescribing after alert implementation were approximately 28 times those during the baseline period (95% CI, 15&#8211;52).</p></sec><sec id="S4"><title>CONCLUSIONS:</title><p id="P4">A targeted decision support alert for patients at risk for opioid overdose significantly increased the rate of naloxone coprescribing and was relatively easy to build. (Anesth Analg 2022;135:26&#8211;34)</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>